does medicaid cover glp-1 drugs covers weight-loss in just 13 states Pennsylvania restricts Medicaid coverage for
Description
The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.
Connect with certified providers on Meto for personalized support and results
DPP-4 inhibitors were introduced for the treatment of type 2 diabetes in 2006
Not for human or veterinary use
GLP-1 drugs like semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and orforglipron (Foundayo) offer promising results for weight loss and health.
Personalized Treatment Options Available At Cape Fear Physical Medicine.
